Researchers at the Crick have found a way to redirect immune cells using F-actin exposed from dead cancer cells, reducing tumour growth in mice.
The technique opens new avenues for developing immunotherapy treatments that complement existing clinical approaches.
www.crick.ac.uk/news/2026-05...
New research from the Francis Crick Institute and Adendra Therapeutics shows that immune cells can be redirected to recognise cancer by exploiting F‑actin, a structural protein exposed when tumour cel...
